BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24886245)

  • 1. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
    Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
    Liu G; Ren X; Gao C; Zhang W
    Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
    Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
    J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
    Li J; Yang L; Song L; Xiong H; Wang L; Yan X; Yuan J; Wu J; Li M
    Oncogene; 2009 Sep; 28(36):3188-96. PubMed ID: 19633686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.
    Hou T; Ou J; Zhao X; Huang X; Huang Y; Zhang Y
    Br J Cancer; 2014 Mar; 110(5):1260-8. PubMed ID: 24423924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
    J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
    Wu Z; Sun H; Zeng W; He J; Mao X
    PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
    Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
    Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
    Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
    J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
    Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
    PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.
    Zheng X; Wang Y; Liu B; Liu C; Liu D; Zhu J; Yang C; Yan J; Liao X; Meng X; Yang H
    Nucleic Acid Ther; 2014 Jun; 24(3):210-6. PubMed ID: 24552182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1.
    Li ZC; Zhang LM; Wang HB; Ma JX; Sun JZ
    Tumour Biol; 2014 Jan; 35(1):111-6. PubMed ID: 23888319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of RasGRP3 in the formation and progression of human breast cancer.
    Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G
    Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
    Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
    Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ; Alfieri CM; Yutzey KE
    Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.